Given that increased expression and activity of FAS and SCD-1 in adipose tissue contribute to the development of obesity and insulin resistance [63,64], decreased lipid synthesis through the inhibition of FAS and SCD-1 expression might contribute to the inhibitory effects of HT077 on adiposity and related metabolic disorders. The gene discussed is SCD; the disease is metabolic disease.